NCT04063488View on ClinicalTrials.gov

The Effects of Metreleptin in Congenital Leptin Deficiency

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

June 20, 2019

Primary Completion Date

August 13, 2021

Study Completion Date

August 13, 2021

Conditions
Congenital Leptin Deficiency (Disorder)
Interventions
DRUG

Metreleptin

This is an observational study in which the subjects will serve as their own controls. Study testing will be conducted at baseline (pre-treatment) and for 2 years, post-treatment with metreleptin.

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT04063488 - The Effects of Metreleptin in Congenital Leptin Deficiency | Biotech Hunter | Biotech Hunter